Mindfulness for Anxiety During the Coronavirus Pandemic
(SMILE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a mindfulness app called SMILE to determine its effectiveness in reducing anxiety caused by COVID-19 stress. Participants will use the app and report on their mental and physical health. The trial compares two mindfulness programs: one led by an instructor online and another self-guided through the app, against a group that waits to try the app. It is well-suited for adults who identify as African American, Black, or Latino and have noticeable anxiety symptoms. As an unphased trial, it provides a unique opportunity to explore innovative methods for managing anxiety.
Will I have to stop taking my current medications?
If you are taking cardiac medications (other than blood pressure medications), seizure medications, or opioids, you will need to stop taking them to participate in this trial.
What prior data suggests that the SMILE app is safe for delivering mindfulness interventions?
Research shows that mindfulness programs are generally safe and manageable for participants. Studies have found that instructor-led mindfulness training, such as the MTIA program, effectively reduces anxiety, depression, and stress without significant side effects. Participants often notice improvements in mental well-being and stress management.
Similarly, mindfulness apps like the MAPP program have shown positive results. One study found that users of these apps experienced clear reductions in stress and anxiety. These apps are easy to use and designed to fit into daily life, making them accessible to many.
Overall, both the MTIA and MAPP programs appear to be safe options for managing anxiety and stress. No major reports of negative side effects have emerged from either approach, suggesting they are well-tolerated by most people.12345Why are researchers excited about this trial?
Researchers are excited about these mindfulness interventions for anxiety during the pandemic because they offer unique approaches compared to traditional treatments like medication and cognitive behavioral therapy. The "MTIA" intervention stands out with its interactive, instructor-led sessions focused on stress, coping, and resilience, delivered online to enhance accessibility and cultural relevance. Meanwhile, the "MAPP" intervention provides a self-paced, app-based experience, allowing individuals to engage with mindfulness exercises flexibly. Both interventions emphasize mindful communication and compassion, offering new avenues for managing anxiety by fostering self-awareness and emotional regulation.
What evidence suggests that this trial's mindfulness interventions could be effective for anxiety?
Research shows that mindfulness practices can effectively reduce anxiety and stress. In this trial, participants may be assigned to different mindfulness interventions. Studies have found that group mindfulness training led by an instructor, such as the MTIA program, lowers stress and anxiety equally well online and in person. For participants in the MAPP program, daily use of mindfulness apps has reduced anxiety and improved well-being, even during stressful times like the COVID-19 pandemic. A review of mindfulness apps suggests they can quickly lessen symptoms of anxiety and depression. Both methods in this trial aim to boost mental health by encouraging mindfulness, which helps people become more aware of their thoughts and feelings.678910
Who Is on the Research Team?
Keri J Heilman, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Susan Gaylord, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Maria Davila, PhD
Principal Investigator
Research Triangle Institute (RTI)
Are You a Good Fit for This Trial?
The SMILE clinical trial is for African American, Black and/or Latino adults experiencing significant anxiety due to COVID-19. Participants must be willing to use the SMILE app and a device that records cardiac data at home. The study excludes details on specific exclusion criteria.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete demographic and psychological questionnaires followed by a HRV assessment protocol
Intervention
Participants in MTIA and MAPP groups participate in an 8-week mindfulness intervention, with biweekly assessments
Follow-up
Participants complete final psychometric and physiological evaluations
What Are the Treatments Tested in This Trial?
Interventions
- Mindfulness
Mindfulness is already approved in United States, European Union, Canada for the following indications:
- Substance Abuse Treatment
- Anxiety Disorders
- Depression
- Stress Management
- Anxiety Disorders
- Chronic Pain
- Depression
- Anxiety Disorders
- Substance Abuse Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
RTI International
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator